Sanara MedTech Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Sanara MedTech (SMTI)
Sanara MedTech Analyst Ratings
Sanara MedTech Analyst Ratings
Cantor Fitzgerald Maintains Overweight on Sanara MedTech, Lowers Price Target to $49
Sanara MedTech Analyst Ratings
Sanara MedTech Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $59 Price Target
Sanara MedTech Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $59 Price Target
Sanara MedTech Analyst Ratings
No Data